Viromed Medical

Heike Perbandt sold a total of 7,500 Viromed Medical shares at €7.05 each on 24 August 2026; previously she had already disposed of 10,000 shares at €7.10 each on 20 August 2026. The stock reacted with losses and traded on the FSE around the day of the disclosure between €6.80 and €6.85. Viromed Medical’s market capitalization currently stands at around €142.76 million, and 20,250,000 shares are tradable. » Plus sur finanzen.net

At Viromed Medical, a closely related executive, Perbandt Heike, sold 10,000 shares on 20.08.2026 at a price of EUR 7.10 each; the transaction was reported on 25.08.2026. On the day of publication the shares fell briefly in FSE trading and later closed at EUR 6.80, having traded earlier between EUR 7.20 and EUR 7.70; 170 shares changed hands that trading day. Already on 06.08.2026, board member Perbandt Uwe had reduced his holding by 50,000 shares at EUR 7.70. Viromed Medical has a market capitalization of around EUR 142.76 million and a free float of 20,250,000 shares. » Plus sur finanzen.net

On 29.07.2026 Heike Perbandt (closely associated) reduced her holding in Viromed Medical by selling 5,000 shares at €7.60 each; the transaction was disclosed on 03.08.2026. After the report, the stock rose briefly in FSE trading and traded at times at €7.75 (+6.20%); on the BaFin publication day it stood at €7.50 (+0.70%). Market capitalization is around €152.89 million, and the free float comprises 20,250,000 shares. Previously, Perbamed Invest GmbH bought 500 shares on 23.06.2026 at €7.34 each. » Plus sur finanzen.net